iPharma iZempic / Semaglutide Compound peptide Pen 5mg - 2ml

Weight Management • Appetite Control • Blood Sugar Support

iPharma iZempic / Semaglutide Pen 5mg

Product Overview iPharma iZempic is an injectable medication containing Semaglutide, a clinically proven GLP-1 receptor agonist. Originally developed to help manage Type 2 diabetes, it has become a leading therapy for weight loss. By mimicking the natural GLP-1 hormone, iZempic regulates appetite, slows digestion, and helps control blood sugar levels, making it highly effective for achieving metabolic balance and sustainable weight reduction.

Key Benefits:

 Semaglutide targets GLP-1 receptors in the body to deliver a multi-faceted approach to metabolic health:

• Appetite Suppression: Reduces hunger and decreases overall calorie intake.
• Increased Satiety: Slows gastric emptying, helping you feel fuller for longer periods.
• Insulin Regulation: Stimulates insulin secretion when blood sugar levels are high.
• Liver Function: Lowers glucose production by the liver.

This combination promotes steady weight loss while improving overall glycemic control.

Disclaimer

This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPRA) for human or animal use.

Not for human consumption or medical use. Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.